Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

U.S. patent covers hemopoietic regulator with potential in rheumatoid arthritis

Sep. 27, 1996

Monoclonal antibody effective in rheumatoid arthritis

Sep. 20, 1996

University of Kentucky's PC-16 for arthritis

Sep. 20, 1996

Progress in arthritis at Toyama

Sep. 13, 1996

Dual TNF production and PDE IV inhibitor from Pfizer

Sep. 13, 1996

Inhibitors of cytokine production reported by SmithKline Beecham

Sep. 13, 1996

Procter & Gamble discloses new matrix metalloproteinase inhibitors

Sep. 13, 1996

COX-2 inhibitors from Merck Frosst

Sep. 13, 1996

A new class of selective COX-2 inhibitors from Merck Frosst

Sep. 13, 1996

CollaGenex and Istituto Gentili collaboration

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...